We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Completion of tuberculosis preventive therapy and associated factors among clients on antiretroviral therapy at Debre Berhan town health facilities, North Shoa Zone, Ethiopia

    Background

    Tuberculosis preventive therapy is vital in caring for HIV-positive individuals, as it prevents the progression from latent tuberculosis...

    Alebachew Zewdu Tegegnework, Muluken Tessema Aemiro, ... Sisay Shewasinad Yehualashet in AIDS Research and Therapy
    Article Open access 25 June 2024
  2. Preventive therapy with galcanezumab for two consecutive cluster bouts in patients with episodic cluster headache: an observational multicenter study

    Background

    Cluster headache is a severe and disabling primary headache disorder. Galcanezumab is a monoclonal antibody against calcitonin gene-related...

    Yooha Hong, Mi-Kyoung Kang, ... Soo-** Cho in The Journal of Headache and Pain
    Article Open access 10 October 2023
  3. Attitudes and perceptions towards develo** a health educational video to enhance optimal uptake of malaria preventive therapy among pregnant women in Uganda: a qualitative study involving pregnant women, health workers, and Ministry of health officials

    Background

    Malaria in pregnancy remains a major global public health problem. Intermittent prophylaxis treatment of malaria in pregnancy with...

    Rita Nakalega, Ruth Nabisere-Arinaitwe, ... Zubair Lukyamuzi in BMC Health Services Research
    Article Open access 18 April 2024
  4. A Dutch cost-effectiveness analysis of fremanezumab versus best supportive care in patients with chronic migraine and inadequate response to prior preventive therapy

    Background

    Chronic migraine (CM) is the most severe and burdensome subtype of migraine. Fremanezumab is a monoclonal antibody that targets the...

    Sharon Wolters, Johannes A. Carpay, ... Maarten J. Postma in BMC Neurology
    Article Open access 24 June 2024
  5. Liver Injury Following Isoniazid Preventive Therapy in HIV Patients Attending Halibet National Referral Hospital, Eritrea: A Prospective Cohort Study

    Introduction

    A 6-month course of isoniazid, 300 mg daily, was programmatically introduced in Eritrea in 2014 as tuberculosis preventive therapy in...

    Mulugeta Russom, Daniel Y. B. Jeannetot, ... Katia M. C. Verhamme in Drugs - Real World Outcomes
    Article Open access 08 June 2023
  6. Reasons for implementation success despite health system constraints: qualitative insights on ‘what worked’ for cotrimoxazole preventive therapy

    Background

    Although Cotrimoxazole preventive therapy (CPT) has shown to be highly efficacious in reducing morbidity and mortality among people living...

    Pia Müller, Edna Mabasso, ... Mohsin Sidat in BMC Health Services Research
    Article Open access 27 March 2024
  7. Unmet Needs in Preventive Treatment of Migraine

    Migraine represents the most common cause of work disability in young women and the second one in the general population. Preventive treatment can...

    Enrico Bentivegna, Dilara Onan, Paolo Martelletti in Neurology and Therapy
    Article Open access 04 February 2023
  8. Factors associated with refusal of preventive therapy after initial willingness to accept treatment among college students with latent tuberculosis infection in Shandong, China

    Background

    Preventive therapy of latent tuberculosis infection (LTBI) is an important component of tuberculosis (TB) control. Research on acceptance...

    Yemin Yuan, ** **, ... Chengchao Zhou in BMC Infectious Diseases
    Article Open access 20 January 2023
  9. The impact of blood transcriptomic biomarker targeted tuberculosis preventive therapy in people living with HIV: a mathematical modelling study

    Background

    Tuberculosis (TB) preventive therapy is recommended for all people living with HIV (PLHIV). Despite the elevated risk of TB amongst PLHIV,...

    Tom Sumner, Simon C. Mendelsohn, ... Richard G. White in BMC Medicine
    Article Open access 29 October 2021
  10. Tuberculosis Preventive Treatment

    Some individuals exposed to Mycobacterium tuberculosis develop a latent infection and remain at a lifelong risk of develo** tuberculosis (TB)...

    Anshula Tayal, S. K. Kabra in Indian Journal of Pediatrics
    Article 14 December 2023
  11. Mid-level managers’ perspectives on implementing isoniazid preventive therapy for people living with HIV in Ugandan health districts: a qualitative study

    Background

    Isoniazid preventive therapy (IPT) works to prevent tuberculosis (TB) among people living with HIV (PLHIV), but uptake remains low in...

    Canice Christian, Elijah Kakande, ... Carol S. Camlin in BMC Health Services Research
    Article Open access 08 March 2024
  12. Position statement of the Brazilian society of Rheumatology on mesna use as a preventive therapy for bladder disease in patients with systemic autoimmune diseases and systemic vasculitis under cyclophosphamide treatment

    Objective

    To review current literature to support the use of mesna as a preventive therapy for hemorrhagic cystitis and bladder cancer in patients...

    Alexandre Wagner S. de Souza, João Gabriel Dantas, ... Ivanio Alves Pereira in Advances in Rheumatology
    Article Open access 21 May 2024
  13. Impact of headache frequency and preventive medication failure on quality of life, functioning, and costs among individuals with migraine across several European countries: need for effective preventive treatment

    Background

    Data are limited regarding the combined impact of headache frequency and failure of preventive medication (efficacy and/or tolerability) on...

    Dawn C. Buse, Patricia Pozo-Rosich, ... Uwe Reuter in The Journal of Headache and Pain
    Article Open access 24 August 2023
  14. Healthcare worker perceived barriers and facilitators to implementing a tuberculosis preventive therapy program in rural South Africa: a content analysis using the consolidated framework for implementation research

    Background

    South African national tuberculosis (TB) guidelines, in accordance with the World Health Organization, recommend conducting routine...

    Brittney J. van de Water, Michael Wilson, ... Norma C. Ware in Implementation Science Communications
    Article Open access 30 August 2023
  15. Sex differences in secondary preventive follow-up after coronary heart events

    Background and aims

    Some studies point to sex differences in cardiovascular preventive practices. The aim of this study was to investigate differences...

    Anete Kaldal, Serena Tonstad, Jarle Jortveit in BMC Cardiovascular Disorders
    Article Open access 14 September 2023
  16. Preventive versus curative photobiomodulation for oral mucositis in patients with multiple myeloma undergoing hematopoietic stem cell transplantation: which approach is more effective?

    Purpose

    There is increasing evidence that photobiomodulation (PBM) therapy is both an effective and safe approach in hematopoietic stem cell...

    Katia Rupel, Arianna Cornacchia, ... Giulia Ottaviani in Supportive Care in Cancer
    Article 05 March 2024
  17. Assessment of contextual factors sha** delivery and uptake of isoniazid preventive therapy among people living with HIV in Dar es salaam, Tanzania

    Background

    Tuberculosis has remained a leading cause of death among people living with HIV (PLHIV) globally. Isoniazid preventive therapy (IPT) is the...

    Renatus Fabiano Nyarubamba, Adam Silumbwe, ... Joseph Mumba Zulu in BMC Infectious Diseases
    Article Open access 24 November 2022
  18. Preventive treatment patterns in the adult migraine population: an observational UK study over 7 years

    Background

    Calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs) are recommended by the United Kingdom National Institute of Health and...

    David Kernick, Nazanin Kondori, ... Tania Gulati in BMC Primary Care
    Article Open access 24 January 2024
  19. Real-world experience with 240 mg of galcanezumab for the preventive treatment of cluster headache

    Background

    Galcanezumab of 300 mg monthly is the FDA approved preventive medication for cluster headache (CH) during the cluster period. Compared to...

    Heejung Mo, Byung-Kun Kim, ... Soo-** Cho in The Journal of Headache and Pain
    Article Open access 08 October 2022
  20. Preventive and restorative alternatives to caries by irradiation: a sco** review

    Purpose

    This study is to conduct a comprehensive sco** review to map scientific evidence and clarify concepts regarding the commonly recommended...

    Renata V. Monteiro, Rodrigo B. E. Lins, ... Grace M. De Souza in Supportive Care in Cancer
    Article 03 May 2024
Did you find what you were looking for? Share feedback.